# Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Shoulder

> **NCT02844738** · PHASE2 · RECRUITING · sponsor: **VivaTech International, Inc.** · enrollment: 4000 (estimated)

## Conditions studied

- Osteoarthritis

## Interventions

- **BIOLOGICAL:** [StroMed + platelet rich plasma (PRP)]

## Key facts

- **NCT ID:** NCT02844738
- **Lead sponsor:** VivaTech International, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2015-07
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 4000 (ESTIMATED)
- **Last updated:** 2025-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02844738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02844738, "Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Shoulder". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02844738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*